The patient‐perceived difficulty in diabetes treatment (PDDT) scale identifies barriers to care

Tamir, Orly; Wainstein, Julio; Abadi-Korek, Ifat; Horowitz, Einav; Shemer, Joshua

doi:10.1002/dmrr.1300

Cited by 12 publications

(16 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These results align with studies from other jurisdictions noting an association between cost and glycemic control [17, 29, 30]. Financial barriers increase the risk of non-adherence and are associated with higher utilization of acute care services among chronic disease patients [18, 31].…”

Section: Discussionsupporting

confidence: 86%

Barriers to care in patients with diabetes and poor glycemic control—A cross-sectional survey

et al. 2017

View full text Add to dashboard Cite

AimsTo determine and quantify the prevalence of patient, provider and system level barriers to achieving diabetes care goals; and to examine whether barriers were different for people with poor glycemic control (HbA1c ≥ 10%; 86 mmol/mol) compared to fair glycemic control (7 to <8%; 53–64 mmol/mol).MethodsWe administered a survey by telephone to community-dwelling patients with diabetes, to examine patient-reported barriers and facilitators to care. We compared responses in individuals with HbA1c ≥ 10% (86 mmol/mol) against those with HbA1c between 7–8% (53–64 mmol/mol). We examined associations between HbA1c group and barriers to care, adjusting for sociodemographic factors and diabetes duration.ResultsThe survey included 805 people with HbA1c ≥ 10% (86 mmol/mol), and 405 people with HbA1c 7–8% (53–64 mmol/mol). Participants with HbA1c ≥ 10% (86 mmol/mol) reported good access to care, however 20% of participants with HbA1c ≥ 10% (86 mmol/mol) felt that their care was not well-coordinated and 9.6% reported having an unmet health care need. In adjusted analysis, patients with HbA1c ≥10% (86 mmol/mol) were more likely to report lack of confidence and inadequate social support, compared to patients with HbA1c 7–8% (53–64 mmol/mol). They were also significantly more likely not to have drug insurance nor to have received recommended treatments because of cost.ConclusionsThese results reinforce the importance of an individualized, yet multi-faceted approach. Specific attention to financial barriers seems warranted. These findings can inform the development of programs and initiatives to overcome barriers to care, and improve diabetes care and outcomes.

show abstract

Section: Discussionsupporting

confidence: 86%

Barriers to care in patients with diabetes and poor glycemic control—A cross-sectional survey

et al. 2017

View full text Add to dashboard Cite

show abstract

“…) or the Patient‐perceived Difficulty in Diabetes Treatment Scale (PDDT) (Tamir et al . ), up to 14, as in the Diabetes Care Profile (Fitzgerald et al . ).…”

Section: Resultsmentioning

confidence: 99%

“…Dimensions Instruments were very heterogeneous in number of items, scales of measurement and dimensions. The range of dimensions went from one, as in the Problem Areas in Diabetes Scale (PAID) (Polonsky et al 1995, Welch et al 1997, the Diabetes Management Self-efficacy Scale (DMSES, UK version) (Sturt et al 2010) or the Patientperceived Difficulty in Diabetes Treatment Scale (PDDT) (Tamir et al 2012), up to 14, as in the Diabetes Care Profile (Fitzgerald et al 1996).…”

Section: Dimensions and Structurementioning

confidence: 99%

Systematic review of the psychometric properties and theoretical grounding of instruments evaluating self‐care in people with type 2 Diabetes Mellitus

Caro‐Bautista

Martín-Santos

Morales-Asencio

2013

Journal of Advanced Nursing

View full text Add to dashboard Cite

show abstract

“…The initial sample comprised 988 adult diabetic patients receiving care in 25 primary care clinics (55% of patients) and multi-disciplinary diabetesspecialized clinics (45% of patients) across Israel, who had been surveyed about their diabetes treatment modality-related perception, attitudes, and quality of life [14]. In our analysis, we aimed to evaluate alternative hypoglycemic pharmaceutical approaches for the orally-treated patients.…”

Section: Study Populationmentioning

confidence: 99%

Quality of Life and Patient-Perceived Difficulties in the Treatment of Type 2 Diabetes

Tamir

Wainstein²,

Shemer³

et al. 2012

Rev Diabet Stud

Self Cite

View full text Add to dashboard Cite

show abstract

The patient‐perceived difficulty in diabetes treatment (PDDT) scale identifies barriers to care

Abstract: The PDDT scale is a simple and valid instrument that may assist in identifying potential barriers in adherence to recommended treatments and to new treatment options.

Cited by 12 publications

References 21 publications

Barriers to care in patients with diabetes and poor glycemic control—A cross-sectional survey

Barriers to care in patients with diabetes and poor glycemic control—A cross-sectional survey

Systematic review of the psychometric properties and theoretical grounding of instruments evaluating self‐care in people with type 2 Diabetes Mellitus

Quality of Life and Patient-Perceived Difficulties in the Treatment of Type 2 Diabetes

Contact Info

Product

Resources

About